EA199800819A1 - METHOD OF TREATMENT OF BIPOLAR DISORDER - Google Patents

METHOD OF TREATMENT OF BIPOLAR DISORDER

Info

Publication number
EA199800819A1
EA199800819A1 EA199800819A EA199800819A EA199800819A1 EA 199800819 A1 EA199800819 A1 EA 199800819A1 EA 199800819 A EA199800819 A EA 199800819A EA 199800819 A EA199800819 A EA 199800819A EA 199800819 A1 EA199800819 A1 EA 199800819A1
Authority
EA
Eurasian Patent Office
Prior art keywords
bipolar disorder
treatment
relates
treating bipolar
olanzapine
Prior art date
Application number
EA199800819A
Other languages
Russian (ru)
Other versions
EA000758B1 (en
Inventor
Чарльз М. мл. Бисли
Гари Д. Толлефсон
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of EA199800819A1 publication Critical patent/EA199800819A1/en
Publication of EA000758B1 publication Critical patent/EA000758B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Abstract

Изобретение относится к способу лечения биполярного расстройства, включающему введение эффективного количества оланзапина пациенту, нуждающемуся в таком лечении. Изобретение относится также к способу лечения биполярного расстройства, такого как приступ сильной депрессии.Международная заявка была опубликована вместе с отчетом о международном поиске.The invention relates to a method of treating bipolar disorder, comprising administering an effective amount of olanzapine to a patient in need of such treatment. The invention also relates to a method of treating bipolar disorder, such as an attack of severe depression. The international application was published together with an international search report.

EA199800819A 1996-03-11 1996-12-04 Method for treating bipolar disorders EA000758B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1315996P 1996-03-11 1996-03-11
PCT/US1996/019575 WO1997033577A1 (en) 1996-03-11 1996-12-04 Method for treating bipolar disorder

Publications (2)

Publication Number Publication Date
EA199800819A1 true EA199800819A1 (en) 1999-02-25
EA000758B1 EA000758B1 (en) 2000-04-24

Family

ID=21758606

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199800819A EA000758B1 (en) 1996-03-11 1996-12-04 Method for treating bipolar disorders

Country Status (15)

Country Link
EP (1) EP0889725A4 (en)
JP (1) JP2000506859A (en)
KR (1) KR19990087713A (en)
CN (1) CN1213966A (en)
AU (1) AU734011B2 (en)
BR (1) BR9612548A (en)
CZ (1) CZ290298A3 (en)
EA (1) EA000758B1 (en)
HU (1) HUP9903679A3 (en)
IL (1) IL126162A0 (en)
NO (1) NO984189L (en)
NZ (1) NZ326031A (en)
PL (1) PL328925A1 (en)
TR (1) TR199801797T2 (en)
WO (1) WO1997033577A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960577B2 (en) 1998-05-22 2005-11-01 Eli Lilly And Company Combination therapy for treatment of refractory depression
PL344331A1 (en) * 1998-05-22 2001-11-05 Lilly Co Eli Combination therapy for treatment of refractory depression
BR9911068A (en) * 1998-05-29 2001-02-06 Lilly Co Eli Combination therapy for the treatment of bipolar disorders
CA2351719A1 (en) * 1998-11-23 2000-06-02 Sepracor Inc. Pharmaceutical compositions containing olanzapine-n-oxide
EP1133299A1 (en) * 1998-11-23 2001-09-19 Sepracor Inc. 2-hydroxymethylolanzapine compositions and methods
AU757973B2 (en) * 1998-11-23 2003-03-13 Sepracor, Inc. Desmethylolanzapine compositions and methods
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use

Also Published As

Publication number Publication date
NO984189D0 (en) 1998-09-11
TR199801797T2 (en) 1998-12-21
EA000758B1 (en) 2000-04-24
HUP9903679A2 (en) 2000-04-28
HUP9903679A3 (en) 2001-10-29
BR9612548A (en) 1999-07-20
NZ326031A (en) 2001-05-25
KR19990087713A (en) 1999-12-27
CN1213966A (en) 1999-04-14
EP0889725A4 (en) 2000-01-19
AU1330797A (en) 1997-10-01
AU734011B2 (en) 2001-05-31
NO984189L (en) 1998-09-11
JP2000506859A (en) 2000-06-06
PL328925A1 (en) 1999-03-01
EP0889725A1 (en) 1999-01-13
IL126162A0 (en) 1999-05-09
CZ290298A3 (en) 1999-10-13
WO1997033577A1 (en) 1997-09-18

Similar Documents

Publication Publication Date Title
EA199800667A1 (en) NEW PHENANTRIDINES
PT966447E (en) SMALL UTILIZATION MOLECULES IN THE TREATMENT OF INFLAMMATORY DISEASES
EA200000351A1 (en) TREATMENT OF CONDUCTIVE VIOLATIONS
IL149890A0 (en) Tnt-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated
TR200000755T2 (en) Treatment of anti-oppositional disorder.
ES2163034T3 (en) MICELLARY COMPOSITIONS OF POLYETER BLOCK COPOLYMERS, FOR THE OBJECTIVATION OF BIOLOGICAL AGENTS AS DIANA.
NO953995L (en) Ion polymers such as anthelmintics in animals
EA199800866A1 (en) METHOD OF REMOVAL OF PAIN
EA199800819A1 (en) METHOD OF TREATMENT OF BIPOLAR DISORDER
EA200200502A1 (en) METHOD OF INTRODUCTION OF PHOSPHODYSTRASE 4 INHIBITOR
PT1237562E (en) PROCESS OF PREPARATION OF MYCANYAN EXTRACTS CONTAINING MICANOLIDE AND DIHYDROMICANOLID AND USES IN THE TREATMENT OF PROLIFERATIVE DISEASES
EA199800864A1 (en) METHOD OF TREATMENT FOR PATIENTS CAUSED BY MIGRAINE
EA199800535A1 (en) METHOD OF TREATMENT OF PAIN
ATE251462T1 (en) METHOD FOR TREATING SCAR TISSUE
ATE293972T1 (en) TREATMENT OF CHRONIC PAIN
EA199800821A1 (en) METHOD OF TREATMENT OF AUTISM
EA199900174A1 (en) METHOD OF TREATMENT OF BIPOLAR DISORDER
EA199800822A1 (en) METHOD FOR TREATING EXCESSIVE AGGRESSION
EA199900006A1 (en) PREPARATION AND METHOD FOR THE TREATMENT OF STRONG HEART FAILURE
IL139303A0 (en) Treatment of arthritis and other similar conditions
EA199800818A1 (en) Method of treating insomnia
ATE268170T1 (en) USE OF SUMMERIC ACID OR SALTS THEREOF TO TREAT INSULIN RESISTANCE
ATE306278T1 (en) TREATING BONE DISEASES WITH ADRENOMEDULLIN
DE69824862D1 (en) COMPOSITIONS FOR IMPROVED Wounds Healing
DE69930419D1 (en) USE OF HUMAN PROTEIN C FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF HEPARINE-INDUCED THROMBOCYTOPENIA

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU